Sorafenib was approved as the first generic in China

The Class 4 chemical generic Sorafenib tosylate tablets (trade name: Ligesitai®) developed by Jiangxi Shanxiang Pharmaceutical Co., Ltd., a subsidiary of Qingfeng Pharmaceutical Group, were approved by the National Medical Products Administration on August 5, 2020. NMPA). The launch of Ligesitai®, announcing that we have officially entered the field of liver cancer treatment.

┃ Ligesitai® Sorafenib Tosylate Tablets